Research

Stony Brook University is currently ranked as one of the top 94 "High Research" institutions by the Carnegie Foundation.  It ranks as one of the top 50 Public Universities in the USA for Research.

The training program in Obstetrics and Gynecology emphasizes the development of the critical analytic skills necessary to read and interpret the published medical literature.

As part of this commitment, the residents are expected to complete one formal research project during their fours years of residency.  These projects are presented at the annual Resident Research Day, held on the day of resident graduation each year.  Each resident chooses a faculty advisor for the project and they work closely with him/her to plan, develop, and carry out their project.  This process is essential for the residents to learn first hand about research and the investigative process.  Many of our residents have been published in notable journals and/or have presented at national conferences.

Our residents have two elective rotations in their second and third year that are often used as research electives.

Some of our past residents have conducted research with investigators outside our Department, and some have conducted basic science research projects that have clinical implications.

As a PGY1, residents learn about research through a didactic program for residents and fellows run by Dr. Laurie Shroyer, PhD, of the Department of Surgery.  Attendance is mandatory for PGY1's. All other residents are encouraged to attend when possible. PGY1's also take the required online training to conduct research (Committee on Research in Human Subjects, or CORIHS Training), prior to initiating a project.  Once mentors and projects are chosen, the resident crafts a proposal which is formally presented at Resident Research Day as a PGY2.   Residents collect and analyze data as a PGY2 -3, and present a finished project at the Annual Resident Research Day as a PGY3.  As a PGY4, the goal is to prepare a formal manuscript for publication, or to present the data at a local or national meeting as a poster or oral presentation.

Our Resident Research program is overseen by Dr. Richard Bronson (REI Division), and Residents gain helpful assistance from our Assistant Vice Chair of Research, Cassandra Heiselman, DO, MPH, who can connect the Resident with the University's resources needed to complete the project. 

Many Residents also have the opportunity to participate in other research projects (aside from the required project).

Posters

Here is a sample of publications by our residents: 

Publications  

2023-2024

  • Stewart L, Parikh B, Woo L, Heiselman C, Garry D, Herrera K. 606 Do social determinants of health influence prescribing practices of low dose aspirin prophylaxis?. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S328-9. https://doi.org/10.1016/j.ajog.2023.11.631
     
  • Korgaonkar-Cherala C, Stetler EH, Stewart L, Ogundipe O, Kim J, Pattanaik R, Garry D, Herrera K, Garretto D, Heiselman C. 55 Infant developmental delays at well visit encounters in infants exposed to MOUD: buprenorphine or methadone. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S42. https://doi.org/10.1016/j.ajog.2023.11.075
     
  • Stetler EH, Yang T, Ogundipe O, Stewart L, Korgaonkar-Cherala C, Kim J, Pattanaik R, Alvarez EZ, Herrera K, Garretto D, Garry D. 603 Differences in dosing strategies and perinatal outcomes for pregnant persons on buprenorphine compared with buprenorphine-naloxone. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S327. https://doi.org/10.1016/j.ajog.2023.11.6
     
  • Ogundipe O, Korgaonkar-Cherala C, Kim J, Stewart L, Stetler EH, Herrera K, Garry D, Heiselman C. 267 Differences in dosing strategies and perinatal outcomes for pregnant patients on buprenorphine compared with methadone. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S155-6. https://doi.org/10.1016/j.ajog.2023.11.289
     
  • Yang T, Kim J, Stetler EH, Chan C, Ogundipe O, Korgaonkar-Cherala C, Stewart L, Alvarez EZ, Monaco GL, Herrera K, Garry D. 365 Antepartum multidisciplinary approach improves postpartum pain scores in patients with opioid use disorder. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S205. https://doi.org/10.1016/j.ajog.2023.11.387
     
  • Stewart L, Woo L, Parikh B, Heiselman C, Garry D, Herrera K. 793 Maternal risk factors for preeclampsia and prescription practices of low dose aspirin for preeclampsia prophylaxis. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S422. https://doi.org/10.1016/j.ajog.2023.11.818
     
  • Stewart L, Parikh B, Woo L, Heiselman C, Garry D, Herrera K. 607 Differences in provider practices in recommending low dose aspirin for preeclampsia prophylaxis. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S329. https://doi.org/10.1016/j.ajog.2023.11.632
     
  • Stewart L, Parikh B, Woo L, Heiselman C, Garry D, Herrera K. 606 Do social determinants of health influence prescribing practices of low dose aspirin prophylaxis?. American Journal of Obstetrics & Gynecology. 2024 Jan 1;230(1):S328-9. https://doi.org/10.1016/j.ajog.2023.11.631
     
  • Fuchs A, Heiselman C, Fassler RP, Korgaonkar-Cherala C, Abuzeid O, Garretto D, Choi J, Herrera K, Garry DJ. Ferritin in the Non-Anemic Pregnant Patient as a Predictor of Anemia at Delivery. American journal of obstetrics & gynecology MFM. 2024 Apr 5:101375. https://doi.org/10.1016/j.ajogmf.2024.101375
     
  • Lee R, Gonsalves Z, Wang S, Hussain A and Herrera K. "Case study: autoimmune hepatitis with cirrhosis and pancytopenia since 7 weeks’ gestation" Case Reports in Perinatal Medicine, vol. 13, no. 1, 2024, pp. 20240007. https://doi.org/10.1515/crpm-2024-0007

 

2022-2023

2021-2022

  • Heiselman C, Fuchs A, Heiligenstein MA, Noureddine LR, Fassler R, Abuzeid O, Korgaonkar-Cherala C, Iovino N, Herrera K,Garretto D, Garry D. Discordance between maternal and newborn drug screening at delivery. American Journal of Obstetrics & Gynecology. 2022 Jan 1;226(1):S37. DOI: https://doi.org/10.1016/j.ajog.2021.11.057
     
  • Abuzeid O, Heiselman C, Fuchs A, Noureddine LR, Heiligenstein MA, Fassler R, Korgaonkar-Cherala C, Iovino N, Garry D,Garretto D, Herrera K. Factors that affect opioid use for postpartum pain control in women with opioid use disorder.American Journal of Obstetrics & Gynecology. 2022 Jan 1;226(1):S133-4. DOI: https://doi.org/10.1016/j.ajog.2021.11.235
     
  • Heiligenstein MA, Fuchs A, Noureddine LR, Fassler R, Abuzeid O, Korgaonkar-Cherala C, Iovino N, Herrera K, Garry D,Garretto D, Heiselman C. Risk Factors for Severe Pain Scores after Delivery in Women with Opioid Use Disorder. AmericanJournal of Obstetrics & Gynecology. 2022 Jan 1;226(1):S535. DOI: https://doi.org/10.1016/j.ajog.2021.11.884
     
  • Noureddine LR, Fuchs A, Heiligenstein MA, Fassler R, Abuzeid O, Korgaonkar-Cherala C, Iovino N, Herrera K, Garry D,Garretto D, Heiselman C. Predictors of Positive Edinburgh Postnatal Depression Scale in Opioid Use Disorder. AmericanJournal of Obstetrics & Gynecology. 2022 Jan 1;226(1):S575-6. DOI: https://doi.org/10.1016/j.ajog.2021.11.953
     
  • Noureddine LR, Parikh B, Saliba E, Monaco GL, Herrera K, Heiselman C. How Comprehensive Are Websites of MaternalFetal Medicine Programs for Prospective Fellows?. American Journal of Obstetrics & Gynecology. 2022 Jan 1;226(1):S140.DOI: https://doi.org/10.1016/j.ajog.2021.11.246
     
  • Gruttadauria M, Pollard J, Kim S, Lian X. Streptococcal toxic shock syndrome in the setting of recent gynecologic surgery: Acase report. Case Rep Women’s’ Health. 2021 Aug 20;32:e00352. PMID: 34466390; PMCID: PMC8385388. DOI: https://doi.org/10.1016/j.crwh.2021.e00352
     
  • Staszewski C, Herrera KM, Kertowidjojo E, Ly V, Iovino N, Garretto D, Kaplan C, Persad MD, Garry DJ. Histological Changes Observed in Placentas Exposed to Medication-Assisted Treatment. Journal of Pregnancy. 2021 Oct 7;2021.
     
  • Chelmow D, Brooks R, Cavens A, Huber-Keener K, Scott DM, Sheth SS, Whetstone S, Worly B, Burke W. Executive Summary of the Uterine Cancer Evidence Review Conference. Obstetrics & Gynecology. 2022 Mar 10:10-97. https://doi.org/10.1097/AOG.0000000000004711
     
  • Chelmow D, Brooks R, Cavens A, Huber-Keener K, Scott DM, Sheth SS, Whetstone S, Worly B, Burke W. Executive summary of the Uterine Cancer Evidence Review Conference. Obstetrics and Gynecology. 2022 Apr;139(4):626. doi: 10.1097/AOG.0000000000004711
     
  • Whetstone S, Burke W, Sheth SS, Brooks R, Cavens A, Huber-Keener K, Scott DM, Worly B, Chelmow D. Health disparities in uterine cancer: report from the Uterine Cancer Evidence Review Conference. Obstetrics and Gynecology. 2022 Apr;139(4):645. doi: 10.1097/AOG.0000000000004710

2020-2021

  • Ajirak M, Heiselman C, Fuchs A, Heiligenstein M, Herrera K, Garretto D, Djuric P. GP-LVM of categorical data from test-positive COVID-19 pregnant women. arXiv preprint arXiv:2011.03715. 2020 Nov 7.
     
  • Arora C, Menzies A, Han ES, Lee M, Lauer JK, Hur HC, Kim JH, Advincula AP. Comparing surgical experience and skill using a high-fidelity, total laparoscopic hysterectomy model. Obstetrics & Gynecology. 2020 Jul 1;136(1):97-108. doi:10.1097/AOG.0000000000003897. 
     
  • Cochrane E, Kim S, Kudelka A, Burke W. Invasive ductal breast carcinoma metastasis to the cervix: A case review and clinical correlation. Gynecologic Oncology Reports. 2020 Aug;33. PMCID: PMC7395300, PMID: 32789159, doi: 10.1016/j.gore.2020.100616
     
  • Cochrane E, Pando C, Kirschen G, Soucier D, Fuchs A, Garry D. Assisted reproductive technologies (ART) and placental abnormalities. Journal of Perinatal Medicine. 2020;48(8): 825-828. https://doi.org/10.1515/jpm-2020-0141
     
  • Cochrane E, Huber A, Jou C, Chappelle J. The effect of an oxytocin washout period on blood loss at cesarean delivery. Journal of Perinatal Medicine. 2020 Oct 1;48(8):799-802. https://doi.org/10.1515/jpm-2020-0038
     
  • DiNobile C, Fuchs A, Herrera K. A case of newly diagnosed autoimmune diabetes in pregnancy presenting after acute onset of diabetic ketoacidosis. Case Reports in Perinatal Medicine. 2021;10(1): 20200042. https://doi.org/10.1515/crpm-2020-0042 
     
  • Fuchs A, Harris L, Huber A, Heiligenstein M, Heiselman C, Herrera K, Garretto D. A case of severe SARS-CoV-2 infection with negative nasopharyngeal PCR in pregnancy. Case Reports in Perinatal Medicine. 2021 Jan 1;10(1). https://doi.org/10.1515/crpm-2020-0075 
     
  • Heiselman C, Iovino N, Herrera K. A case report of co-infection with rhinovirus and SARS-CoV-2 in pregnancy. Case Reports in Perinatal Medicine. October 2020;9(1): 20200028. https://doi.org/10.1515/crpm-2020-0028 
     
  • Herrera KM, Milone G, Davis JA, Persad MD, Dinglas C, Heiselman C, Buckley A, Garretto D, Pastore LM. Psychological measures of patient’s decision-making for prenatal genetic testing. The Journal of Maternal-Fetal & Neonatal Medicine. 2020 Nov 10:1-7. doi: 10.1080/14767058.2020.1847074. 
     
  • Kim S, Pollard J, Garretto D, Herrera K. Cardiac implant and the risk of infective endocarditis in pregnancy. Case Reports in Perinatal Medicine. November 2020;9(1): 20200023. https://doi.org/10.1515/crpm-2020-0023
     
  • Staszewski C, Garretto D, Garry E, Ly V, Davis J, Herrera K. Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies. Journal of Perinatal Medicine. 2020;48(7): 677-680. PMID: 32681781 DOI: 10.1515/jpm-2020-0106

2019-2020

  • Staszewski C, Herrera K, Persad MD, Garretto D, Davis J, Garry D. Influence of Psychiatric Medications on Neonatal Abstinence Syndrome in Women Treated for Opioid Use Disorder [17E]. Obstetrics and Gynecology. 2020 May 1;135:54S. doi: 10.1097/01.AOG.0000663484.60748.c8
     
  • Buckley A, Milone G, Chittineedi N. Does a Second Stage Cesarean Section Increase the Risk of Cervical Insufficiency in Future Pregnancies. Gynecol Reprod Health. 2020;4(3):1-3
     
  • Cochrane E, Frost K, Dinobile C, Kim S, Burke W. Immature teratoma diagnosed and treated during pregnancy and later complicated by growing teratoma syndrome: a case review with clinical considerations. Gynecol Oncol Rep. 2020:32. May. doi: 10.1016/j.gore.2020.100566
     
  • Dinglas C, Afsar N, Cochrane E, Davis J, Kim S, Akerman M, Wells M, Chavez M, Herrera K, Heo H, Vintzileos A. First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease. American Journal of Obstetrics and Gynecology. 2020 May 1;222(5):499-e1. doi: 10.1016/j.ajog.2019.11.126
     
  • Kirschen GW, Pollard J, Herrera K. One If by Vaginal, Two If by C (Section): An Argument for Vaginal Delivery for Hemophilia A Carriers with Male Fetuses. Arch Clin Case Stud. 2(1): 2019. ACCS.MS.ID.000527. DOI: 10.33552/ACCS.2019.02.000527